Scarica l'app Stockscreener
33.35
0.33%
-0.11
Dopo l'orario di chiusura:
33.35
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Ritholtz Wealth Management Has $968,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Burney Co. Sells 38,157 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $43.80 - Defense World
Collegium pharmaceutical EVP Shirley Kuhlmann sells $908,627 in stock By Investing.com - Investing.com Australia
Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 27,500 Shares of Stock - MarketBeat
Despite the downward trend in earnings at Collegium Pharmaceutical (NASDAQ:COLL) the stock swells 18%, bringing three-year gains to 82% - Simply Wall St
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Has $10.71 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Earns Buy Rating from HC Wainwright - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Raised to “Buy” at Needham & Company LLC - Defense World
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Needham & Company LLC - MarketBeat
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Unveils 2025 Financial Projections - Yahoo Finance
COLLCollegium Pharmaceutical, Inc. Latest Stock News & Market Updates - StockTitan
Collegium Pharmaceutical (NASDAQ:COLL) Trading 2.8% HigherShould You Buy? - MarketBeat
Collegium Pharma stock spikes on 2025 outlook (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical, Inc. Provides Earnings Guidance for the Year 2025 -January 08, 2025 at 08:00 am EST - Marketscreener.com
Collegium Provides 2025 Financial Guidance and Business Update - GlobeNewswire
Collegium Pharmaceutical Projects Record $750M Revenue in 2025, ADHD Drug Leads Growth - StockTitan
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month LowHere's What Happened - MarketBeat
Collegium stock hits 52-week low at $28.46 amid market challenges - Investing.com Australia
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month LowWhat's Next? - MarketBeat
Franklin Resources Inc. Has $1.16 Million Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Geode Capital Management LLC Has $29.97 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus - Yahoo Finance
Sanctuary Advisors LLC Buys 1,731 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Barclays PLC - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Barclays PLC - Defense World
Collegium Pharmaceutical stock hits 52-week low at $28.75 By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical stock hits 52-week low at $28.75 - Investing.com
Improved Revenues Required Before Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Find Their Feet - Simply Wall St
When the Price of (COLL) Talks, People Listen - Stock Traders Daily
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 1-Year LowWhat's Next? - MarketBeat
Principal Financial Group Inc. Has $67.46 Million Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $42.60 - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Wellington Management Group LLP Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Holdings Lifted by Fmr LLC - Defense World
Fmr LLC Increases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies? - Marketscreener.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.29 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
The Manufacturers Life Insurance Company Sells 816 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Janus Henderson Group PLC Boosts Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com
Loomis Sayles & Co. L P Has $737,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Penserra Capital Management LLC Buys New Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Rubric Capital Management LP Reduces Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60 - Defense World
Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha
Massachusetts Financial Services Co. MA Increases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
0.94%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):